Geri-Care Over-the-Counter Drugs Recalled for Non-Child-Resistant Packaging
Geri-Care Pharmaceuticals is recalling about 800 bottles of over-the-counter acetaminophen and aspirin tablets because the packaging is not child resistant, posing a poisoning risk to young children.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This recall involves a risk-of-harm product (regulated drugs in non-compliant packaging that could be ingested by young children), with no reported illnesses or injuries to date. Per the rubric, a risk-of-harm product where injury has not yet been reported scores 3 (High).
Plain-English summary
Geri-Care Pharmaceuticals of Brooklyn, New York is recalling bottles of Geri-Care brand over-the-counter acetaminophen and aspirin tablets. The recalled products include Extra Strength Acetaminophen 500mg tablets (1,000-count bottle), Regular Strength Enteric Coated Aspirin 325mg tablets (250-count and 1,000-count bottles), and Adult Low Dose Enteric Coated Aspirin 81mg tablets (300-count and 1,000-count bottles). About 800 units are affected.
The recalled products contain regulated substances that must be packaged in child-resistant packaging under the Poison Prevention Packaging Act (PPPA). The packaging of these products is not child resistant, creating a risk of poisoning if young children swallow the contents.
The products were sold online through multiple retailers including Amazon, eBay, and various medical supply websites through August 2021, priced between $2 and $1. No injuries or illnesses have been reported.
Consumers should immediately store the recalled products in a safe location out of sight and reach of children and safely dispose of them as soon as practicable. Contact Geri-Care Pharmaceuticals at 800-540-3765 (Monday–Thursday 9 a.m.–5 p.m. ET, Friday 9 a.m.–1 p.m. ET), email [email protected], or visit www.gericarepharm.com/recalls/ for a full refund or replacement product.
The recalled product
- Product
- Over-the-counter drugs
- Manufacturer
- Geri-Care Pharmaceuticals, of Brooklyn, New York
- Hazard
- child-resistant-packaging-failure
- poisoning-risk
- Affected units
- 800
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateMedline Ophthalmic Pack with Lidocaine Injection Kits Recalled
FDA (Devices) · 2026-07-08
- SevereAccucaine Lidocaine Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-08
- SevereChloraPrep One-Step Sterile Solution Lacks Assurance of Sterility
FDA (Drugs) · 2026-07-08
- SevereChloraPrep One-Step Antiseptic Applicators recalled for lack of sterility assurance
FDA (Drugs) · 2026-07-08